CVM
Cel-Sci Corporation (CVM)
$
08About Cel-Sci Corporation (CVM)
CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
Details
Daily high
$1.11
Daily low
$1.05
Price at open
$1.08
52 Week High
$3.23
52 Week Low
$1.02
Market cap
66.4M
Dividend yield
0.00%
Volume
1,707
Avg. volume
350,692
P/E ratio
-1.90
Cel-Sci Corporation News
Details
Daily high
$1.11
Daily low
$1.05
Price at open
$1.08
52 Week High
$3.23
52 Week Low
$1.02
Market cap
66.4M
Dividend yield
0.00%
Volume
1,707
Avg. volume
350,692
P/E ratio
-1.90